title: Evaluation of human relevance and mode of action for tunica vaginalis mesotheliomas resulting from oral exposure to acrylamide.
abstract: The human relevance and mode of action of acrylamide-related tunica vaginalis mesotheliomas (TVMs), a tumor of the scrotum, was evaluated based on the available data on acrylamide and general biology considerations. TVMs are found almost exclusively in F344 rats, suggesting an association with the hormonal milieu unique to F344s, and suggesting an association with Leydig cell tumors (LCTs), which occur in F344 rats at a very high incidence. These hypotheses are biologically plausible, but direct data on acrylamide were lacking for several key events; some of the gaps could be addressed based on other biology information. The data were not sufficient to identify a single definitive MOA. Multiple MOAs may apply, and some contribution from mutagenicity is plausible, along with a likely influence from LCTs or from the same hormonal changes that result in higher LCT incidence in F344 rats. Other MOAs, such as oxidative stress, may also apply. The data reviewed are not sufficient to distinguish between a causal relationship between LCTs and TVMs, and the hypothesis that these tumor types reflect a response to some shared influence (e.g., hormonal milieu of the F344 rat). Some of the plausible MOAs are not relevant to humans, while others are. In light of the very low incidence of TVMs in humans and the MOA data reviewed, the most appropriate upper bound estimate of the risk of acrylamide-related TVMs in humans is below de minimis levels.
authors.affiliation: Toxicology Excellence for Risk Assessment, 2300 Montana Avenue, Suite 409, Cincinnati, OH 45211, USA. Haber@tera.org
authors.forename: Lynne T
authors.initials: LT
authors.lastname: Haber
authors.forename: Andrew
authors.initials: A
authors.lastname: Maier
authors.forename: Oliver L
authors.initials: OL
authors.lastname: Kroner
authors.forename: Melissa J
authors.initials: MJ
authors.lastname: Kohrman
mesh_terms: D020106:Acrylamide / Q000633:toxicity*; D000284:Administration, Oral; D000818:Animals; D006801:Humans; D007984:Leydig Cell Tumor / Q000139:chemically induced / Q000473:pathology; D008297:Male; D008654:Mesothelioma / Q000139:chemically induced* / Q000473:pathology; D051381:Rats; D018570:Risk Assessment; D013045:Species Specificity; D013736:Testicular Neoplasms / Q000139:chemically induced* / Q000473:pathology
chemical_list: D020106:Acrylamide